Инструкция по применению LOROS
GLOROS
“80 mg Effervescent Granulate”
Ferrous Gluconate
Equivalent Medicinal Product
PHARMACOTHERAPEUTIC CATEGORY
Iron-based antianemic agents.
THERAPEUTIC INDICATIONS
Treatment of iron deficiency anemias.
CONTRAINDICATIONS
Hypersensitivity to the active substance or to any of the excipients listed in Composition.
Hemosiderosis, hemochromatosis, all non-sideropenic anemic conditions, in particular hemolytic
anemias, chronic pancreatitis, hepatic cirrhosis.
Iron preparations are contraindicated in cases of active peptic ulcer, Crohn's disease
and ulcerative colitis.
Ferrous gluconate is contraindicated in patients receiving repeated blood transfusions, or in
patients receiving iron therapy via the parenteral route.
PRECAUTIONS FOR USE
Ferrous gluconate should be used with caution in patients suffering from intestinal stenosis and
diverticula.
Treatment must be preceded by a precise diagnosis of sideropenic anemia.
The administration of iron may be toxic, especially in children, at doses higher than
400 mg (more than 5 sachets)
In order to avoid a possible risk of iron overdose, particular attention must be paid if dietary
supplements or other iron salt supplements are used.
In case of pre-existing inflammation or ulceration of the gastrointestinal mucosa, the benefits
of treatment must be carefully evaluated against the risk of worsening of the
gastrointestinal disease.
INTERACTIONS
Inform your doctor or pharmacist if you have recently taken any other medicines,
including those without a prescription.
Iron salts reduce the absorption of tetracyclines, penicillamines, levodopa and methyldopa.
There may be a risk of toxicity with penicillamine when treatment with
iron derivatives is stopped.
Iron-based medicines interfere with the absorption of quinolone antibiotics (e.g.
ciprofloxacin, levofloxacin, norfloxacin, ofloxacin)
Iron salts reduce the absorption of thyroxine in patients undergoing thyroxine replacement therapy.
The absorption of iron is reduced by the concomitant use of cholestyramine as well as calcium and magnesium supplements.
Iron salts may reduce the absorption of mycophenolate.
The concomitant use of iron salts and salicylates or non-steroidal anti-inflammatory drugs
may enhance the irritant effect of iron on the gastrointestinal mucosa.
Antacid preparations (magnesium or aluminum salts) reduce the absorption of iron. An interval of 2-3
hours should elapse between the administration of GLOROS and the administration of antacid preparations.
SPECIAL WARNINGS
Ask your doctor or pharmacist for advice before taking any medicine.
PREGNANCY AND BREASTFEEDING
Pregnancy
The product can be administered during pregnancy.
The iron requirement in the second part of pregnancy is approximately around 6 mg/day.
In case of iron deficiency, the dosage must be adjusted according to the response to
therapy and gastrointestinal tolerance.
A high dose is better tolerated if divided into 3 or 4 administrations.
Breastfeeding
It is not known whether GLOROS is excreted in breast milk.
The risk to infants/breastfeeding mothers cannot be excluded.
Effects on ability to drive and use machines
No effects on the ability to drive and use machines have been observed.
Important information about some excipients
This medicine contains a source of phenylalanine. It may be harmful if you have phenyl-
ketonuria. Each sachet of GLOROS effervescent granules contains 8.01 mEq of so-
dium; to be taken into consideration in people with reduced renal function or who are following
a low-sodium diet.
This medicine contains sucrose, therefore if your doctor has diagnosed you with an intolerance to
certain sugars, contact him before taking this medicine
DOSAGE, ADMINISTRATION AND DURATION OF TREATMENT
The daily requirement in adult subjects (male) is generally 13 g/kg or 1
mg/day.
The daily requirement for female subjects (normal menstruation) is generally 21 g/kg or 1.4 mg/day.
During the last 6 months of pregnancy, the requirement increases: 80 g/kg/day or, generally,
from 5 to 6 mg/day.
Children: 22 g/kg.
In case of iron deficiency, the dose should be between 50 and 250 mg/day, depending on
the degree of anemia.
DOSAGE
Adults
One sachet of effervescent granules per day, dissolved in water ½ hour before a meal.
In case of severe anemia, the dose may be modified at the doctor's discretion based on
hematological examinations to be performed 2 or 3 times a week after the start of treatment.
Children
From ½ to 1 sachet depending on body weight.
If anemia persists after 3 weeks of treatment, another cause should be investigated.
OVERDOSE
In case of overdose of iron salts, the patient may present with epigastric pain, nausea, vo-
miting, diarrhea and hematemesis, often associated with drowsiness, pallor, cyanosis, shock, up to co-
ma.
Treatment should be as prompt as possible and consists of the administration of an
emetic, followed possibly by gastric lavage, and in performing appropriate supportive therapy.
The opportunity to administer an iron chelating agent, such as desferoxamine, should also be evaluated.
An overdose due to accidental administration of a high dose is fatal for
children.
It is therefore essential to keep the medicine out of reach of children.
In case of accidental ingestion/taking of an excessive dose of GLOROS, immediately warn
the doctor or go to the nearest hospital.
If you have any doubts about the use of GLOROS, consult your doctor or pharmacist
UNDESIRABLE EFFECTS
Like all medicines, GLOROS can cause side effects, although not everyone
experience them.
The undesirable effects associated with GLOROS are listed below according to classification
for organs and systems.
Gastrointestinal disorders
Vomiting, nausea, diarrhea (which in case of overdose may be severe and complicated by
gastrointestinal bleeding, see “Overdose”).
During the administration of iron-containing preparations, a harmless co-
loration of the stool black or dark urine or temporary discoloration of the teeth may occur.
Immune system disorders
Rarely, allergic reactions may occur
SHELF LIFE AND STORAGE
Shelf life: see the expiry date reported on the packaging.
The expiry date indicated refers to the product in intact packaging, correctly
stored.
Caution: do not use the medicine after the expiry date reported on the packaging.
Store at a temperature not exceeding 25°C
Keep the medicine out of reach and sight of children.
Medicines should not be disposed of via drains or household waste.
Ask your pharmacist how to dispose of medicines you no longer use. This will help to pro-
tect the environment.
COMPOSITION
One sachet of effervescent granules contains:
Active Ingredient: Ferrous Gluconate mg 695 (equivalent to 80 mg of Fe++)
Excipients: Ascorbic acid, Citric acid, Tartaric acid, Sodium bicarbonate, Sodium carbona-
te monohydrate, Sodium saccharinate, Aspartame, Sucrose, Orange aroma, Yellow orange (E
110)
PHARMACEUTICAL FORM AND CONTENT
Effervescent granules in packs of 30 or 40 sachets
MARKETING AUTHORISATION HOLDER
ELLEVA PHARMA S.r.l.
Via San Francesco n. 5/7
80034 Marigliano (NA)
MANUFACTURER
LA.FA.RE. srl – Pharmaceutical Laboratory
Via Sac. Benedetto Cozzolino 77
80056 Ercolano-Naples
DRUG CODE:
- Страна регистрации
- Форма выпускаEffervescent granules, 80 MG
- Код АТХB03AA03
- Действующее вещество
- Отпускается по рецептуНет
- Производитель
- Информация на этой странице носит справочный характер и не является медицинской консультацией. Перед началом приема лекарства обязательно проконсультируйтесь с врачом.
- Аналоги LOROSФорма выпуска: Effervescent tablet, 80 MGДействующее вещество: ferrous gluconateПроизводитель: A. MENARINI INDUSTRIE FARMACEUTICHE RIUNITE S.R.L.Отпускается без рецептаФорма выпуска: Oral solution, 126 MG/10 MLДействующее вещество: ferrous gluconateПроизводитель: PHARMAFAR S.R.L.Отпускается без рецептаФорма выпуска: Effervescent tablet, 80 MGДействующее вещество: ferrous gluconateПроизводитель: EG S.P.A.Отпускается без рецепта
Аналоги LOROS в других странах
Лекарства с тем же действующим веществом, доступные в других странах.
Аналог LOROS в Польша
Аналог LOROS в Испания
Врачи онлайн по LOROS
Обсудите применение LOROS и возможные следующие шаги — по оценке врача.
Получите рецепт на LOROS онлайн
Заполните форму за 2 минуты
Расскажите о симптомах, истории болезни и нужном препарате.
Выберите врача или мы назначим
Выберите специалиста или мы подберём ближайшего доступного врача.
Врач рассматривает ваш случай
Обычно в течение 30 минут. Может задать уточняющие вопросы в чате.
Получите в любой аптеке
Электронный рецепт отправляется на вашу почту — действителен по всей Польше.
Часто задаваемые вопросы
LOROS не требует рецепта в Италия. Вы можете уточнить у врача онлайн, подходит ли это лекарство для вашей ситуации.
Действующее вещество LOROS — ferrous gluconate. Эта информация помогает определить лекарства с тем же составом под другими торговыми названиями.
LOROS производится компанией ELLEVA PHARMA SRL. Упаковка и торговое название могут отличаться в зависимости от дистрибьютора.
Врачи, включая Семейные врачи, Психиатры, Дерматологи, Кардиологи, Эндокринологи, Гастроэнтерологи, Пульмонологи, Нефрологи, Ревматологи, Гематологи, Инфекционисты, Аллергологи, Гериатры, Педиатры, Онкологи, могут оценить целесообразность применения LOROS с учетом вашей ситуации и местных правил. Вы можете записаться на онлайн-консультацию, чтобы обсудить возможные варианты.
Польша имеет хорошо развитую систему здравоохранения в крупных городах, таких как Варшава, Краков, Вроцлав и Гданьск. Аптеки широко доступны и работают в соответствии с действующим законодательством, обеспечивая доступ к рецептурным препаратам.
Вы можете купить LOROS в Варшаве, Кракове, Вроцлаве или Гданьске в любой аптеке при наличии действующего рецепта.
Чтобы получить рецепт, вы можете воспользоваться Oladoctor:
Другие лекарства с тем же действующим веществом (ferrous gluconate) включают KROMATONFERRO, FERRO KOMPLEX, FERRO LUKONATO EG. Они могут отличаться торговым названием или формой выпуска, но содержат одинаковый терапевтический компонент. Перед изменением лечения рекомендуется проконсультироваться с врачом.
















